Study on recovery molecules in severe infections
Part of Infections clinical trials.
This trial looks at natural molecules that help the body resolve severe infections. Researchers want to understand how these molecules affect recovery and identify patient types that respond best. It may help improve treatment for people in the ICU with serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are in the intensive care unit (ICU)
- You have a severe infection or sepsis, as diagnosed by your doctor
- You can have a blood sample taken within the first 1 to 2 days in the ICU as part of your normal care
- You or your legal representative agrees to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
This trial studies treatments for sepsis, a serious infection complication, in ICU patients. It aims to find better ways to care for critically ill patients with sepsis.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.